Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
Debt to Assets Over Time
Trending lower, above historical average, strong compound growth.
Left:
||||
Debt-to-assets ratio
Latest
0.51
↑ 151% above average
Average (9y)
0.20
Historical baseline
Range
High:0.75
Low:0.00
CAGR
+42.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | 0.51 | -32.3% |
| 2024 | 0.75 | +49.2% |
| 2023 | 0.50 | +324.9% |
| 2022 | 0.12 | +227.7% |
| 2021 | 0.04 | -11.1% |
| 2020 | 0.04 | - |
| 2019 | 0.00 | -100.0% |
| 2018 | 0.02 | -14.5% |
| 2017 | 0.02 | +14.4% |
| 2016 | 0.02 | - |